179 related articles for article (PubMed ID: 36914775)
1. Transcranial focused ultrasound-mediated unbinding of phenytoin from plasma proteins for suppression of chronic temporal lobe epilepsy in a rodent model.
Kim E; Kim HC; Van Reet J; Böhlke M; Yoo SS; Lee W
Sci Rep; 2023 Mar; 13(1):4128. PubMed ID: 36914775
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats.
van Vliet EA; van Schaik R; Edelbroek PM; Redeker S; Aronica E; Wadman WJ; Marchi N; Vezzani A; Gorter JA
Epilepsia; 2006 Apr; 47(4):672-80. PubMed ID: 16650133
[TBL] [Abstract][Full Text] [Related]
3. Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy.
Bethmann K; Brandt C; Löscher W
Epilepsia; 2007 Apr; 48(4):816-26. PubMed ID: 17319923
[TBL] [Abstract][Full Text] [Related]
4. Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy.
Fang Z; Chen S; Qin J; Chen B; Ni G; Chen Z; Zhou J; Li Z; Ning Y; Wu C; Zhou L
Biomaterials; 2016 Aug; 97():110-21. PubMed ID: 27162079
[TBL] [Abstract][Full Text] [Related]
5. Localized Disruption of Blood Albumin-Phenytoin Binding Using Transcranial Focused Ultrasound.
Xu L; Lee W; Rotenberg A; Böhlke M; Yoon K; Yoo SS
Ultrasound Med Biol; 2020 Aug; 46(8):1986-1997. PubMed ID: 32402673
[TBL] [Abstract][Full Text] [Related]
6. In vivo binding characteristics of phenytoin to serum proteins in monotherapy for adults with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
Am J Ther; 2000 Nov; 7(6):359-63. PubMed ID: 11304643
[TBL] [Abstract][Full Text] [Related]
7. Effects of phenytoin, carbamazepine, and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy.
Schumacher TB; Beck H; Steinhäuser C; Schramm J; Elger CE
Epilepsia; 1998 Apr; 39(4):355-63. PubMed ID: 9578025
[TBL] [Abstract][Full Text] [Related]
8. Pluronic P85 decreases the delivery of phenytoin to the brain in drug-resistant rats with P-glycoprotein overexpressed chronic mesial temporal lobe epilepsy.
Fang Z; Cao P; Pan N; Lu H
IBRO Neurosci Rep; 2023 Dec; 15():100-106. PubMed ID: 37485299
[TBL] [Abstract][Full Text] [Related]
9. Selection of phenytoin responders and nonresponders in male and female amygdala-kindled Sprague-Dawley rats.
Löscher W; Cramer S; Ebert U
Epilepsia; 1998 Nov; 39(11):1138-47. PubMed ID: 9821977
[TBL] [Abstract][Full Text] [Related]
10. Vigabatrin versus carbamazepine and phenytoin in kainic acid-treated pubescent rats.
Mecarelli O; De Feo MR; Del Priore D
Pharmacol Res; 1997 Aug; 36(2):87-93. PubMed ID: 9344635
[TBL] [Abstract][Full Text] [Related]
11. Anticonvulsant efficacy of topiramate in phenytoin-resistant kindled rats.
Reissmüller E; Ebert U; Löscher W
Epilepsia; 2000 Apr; 41(4):372-9. PubMed ID: 10756400
[TBL] [Abstract][Full Text] [Related]
12. In vivo binding characteristics of phenytoin to serum proteins in monotherapy pediatric patients with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Itokazu N; Sugimoto T
Int J Clin Pharmacol Ther; 2000 Jan; 38(1):25-9. PubMed ID: 10667833
[TBL] [Abstract][Full Text] [Related]
13. Phenytoin- and carbamazepine-resistant spontaneous bursting in rat entorhinal cortex is blocked by retigabine in vitro.
Smith MD; Adams AC; Saunders GW; White HS; Wilcox KS
Epilepsy Res; 2007 May; 74(2-3):97-106. PubMed ID: 17395429
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of multidrug resistance-associated protein 2 in the brain of pentylenetetrazole-kindled rats.
Yao D; Liu L; Jin S; Li J; Liu XD
Neuroscience; 2012 Dec; 227():283-92. PubMed ID: 23059797
[TBL] [Abstract][Full Text] [Related]
15. Effect of temperature on binding characteristics of phenytoin to serum proteins in monotherapy adult patients with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
Am J Ther; 2000 Jan; 7(1):11-5. PubMed ID: 11319568
[TBL] [Abstract][Full Text] [Related]
16. Injectable phenytoin loaded polymeric microspheres for the control of temporal lobe epilepsy in rats.
Jiang JL; Yue Z; Bauquier SH; Lai A; Chen Y; McLean KJ; Halliday AJ; Sui Y; Moulton S; Wallace GG; Cook MJ
Restor Neurol Neurosci; 2015; 33(6):823-34. PubMed ID: 26484695
[TBL] [Abstract][Full Text] [Related]
17. Temperature effect on serum protein binding kinetics of phenytoin in monotherapy patients with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
Eur J Pharm Biopharm; 1999 May; 47(3):295-8. PubMed ID: 10382115
[TBL] [Abstract][Full Text] [Related]
18. Intranasal delivery of phenytoin-loaded nanoparticles to the brain suppresses pentylenetetrazol-induced generalized tonic clonic seizures in an epilepsy mouse model.
Yousfan A; Rubio N; Al-Ali M; Nattouf AH; Kafa H
Biomater Sci; 2021 Nov; 9(22):7547-7564. PubMed ID: 34652351
[TBL] [Abstract][Full Text] [Related]
19. Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate.
Della Paschoa OE; Voskuyl RA; Danhof M
Br J Pharmacol; 1998 Dec; 125(7):1610-6. PubMed ID: 9884091
[TBL] [Abstract][Full Text] [Related]
20. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
